Preclinical activity and safety of MGD006, a CD123xCD3 Bispecific DART® molecule for the treatment of hematological malignancies

被引：3
|
作者：
Moore, P. [1 ]
Chichili, G. R. [1 ]
Huang, L. [1 ]
Li, H. [1 ]
Burke, S. [1 ]
Chen, F. [2 ]
He, L. [1 ]
Tang, Q. [1 ]
Jin, L. [1 ]
Gorlatov, S. [1 ]
Ciccarone, V. [1 ]
Koenig, S. [1 ]
Shannon, M. [1 ]
Alderson, R. [1 ]
Johnson, S. [1 ]
Bonvini, E. [1 ]
机构：
[1] MacroGenics, Rockville, MD USA
[2] MacroGenics, San Francisco, CA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70264-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
138
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [1] Immune Senescence and Exhaustion Correlate with Response to Flotetuzumab, an Investigational CD123xCD3 Bispecific Dart® Molecule, in Acute Myeloid Leukemia
    Vadakekolathu, Jayakumar
    Yau, Tung On
    Church, Sarah E.
    Rettig, Michael P.
    Aldoss, Ibrahim
    Uy, Geoffrey L.
    Vey, Norbert
    Emadi, Ashkan
    Sayre, Peter H.
    Walter, Roland B.
    Foster, Matthew C.
    Arellano, Martha L.
    Godwin, John E.
    Wieduwilt, Matthew J.
    Byrne, Michael T.
    Michaelis, Laura C.
    Stiff, Patrick J.
    Carrabba, Matteo Giovanni
    Chevalier, Patrice
    Gyan, Emmanuel
    Recher, Christian
    Advani, Anjali S.
    Wermke, Martin
    Erba, Harry P.
    Ciceri, Fabio
    Huls, Geert
    Jongen-Lavrencic, Mojca
    Ravandi, Farhad
    Curti, Antonio
    Topp, Max S.
    Muth, John
    Kaminker, Patrick
    Lowenberg, Bob
    Gojo, Ivana
    Luznik, Leo
    DiPersio, John F.
    Davidson-Moncada, Jan K.
    Rutella, Sergio
    BLOOD, 2020, 136
  • [2] A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates
    Chichili, Gurunadh R.
    Huang, Ling
    Li, Hua
    Burke, Steve
    He, Leilei
    Tang, Qin
    Jin, Linda
    Gorlatov, Sergey
    Ciccarone, Valentina
    Chen, Francine
    Koenig, Scott
    Shannon, Michele
    Alderson, Ralph
    Moore, Paul A.
    Johnson, Syd
    Bonvini, Ezio
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (289)
  • [3] Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells
    Kuo, Shu-Ru
    Wong, Lucas
    Liu, Jen-Sing
    PROTEIN ENGINEERING DESIGN & SELECTION, 2012, 25 (10): : 561 - 569
  • [4] Development of a CD123xCD3 bispecific antibody to treat acute myeloid leukemia (AML)
    Gaudet, Francois
    Nemeth, Jennifer F.
    McDaid, Ronan
    Li, Yingzhe
    Harman, Benjamin
    Millar, Hillary
    Teplyakov, Alexey
    Wheeler, John
    Luo, Jinquan
    Tam, Susan
    Wu, Sheng-Jiun
    Chen, Emily
    Babich, Alexander
    Elsayed, Yusri
    Attar, Ricardo
    CANCER RESEARCH, 2016, 76
  • [5] Immune Landscapes Predict Chemotherapy Resistance and Anti-Leukemic Activity of Flotetuzumab, an Investigational CD123xCD3 Bispecific Dart® Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Vadakekolathu, Jayakumar
    Minden, Mark D.
    Hood, Tressa
    Church, Sarah E.
    Reeder, Stephen
    Altmann, Heidi
    Sullivan, Amy H.
    Viboch, Elena J.
    Patel, Tasleema
    Ibrahimova, Narmin
    Warren, Sarah E.
    Arruda, Andrea
    Schmitz, Marc
    Liang, Yan
    Cesano, Alessandra
    Pockley, A. Graham
    Valk, Peter
    Lowenberg, Bob
    Bornhauser, Martin
    Tasian, Sarah K.
    Rettig, Michael P.
    Davidson-Moncada, Jan K.
    DiPersio, John F.
    Rutella, Sergio
    BLOOD, 2019, 134
  • [6] Development of a CD123xCD3 Bispecific Antibody (JNJ-63709178) for the Treatment of Acute Myeloid Leukemia (AML)
    Gaudet, Francois
    Nemeth, Jennifer F.
    McDaid, Ronan
    Li, Yingzhe
    Harman, Benjamin
    Millar, Hillary
    Teplyakov, Alexey
    Wheeler, John
    Luo, Jinquan
    Tam, Susan
    Wu, Sheng-Jiun
    Chen, Emily
    Rudnick, Stephen
    Chu, Gerald
    Hughes, Anna
    Luistro, Leopoldo
    Chin, Diana
    Babich, Alexander
    Kalota, Anna
    Singh, Indrajeet
    Salvati, Mark
    Elsayed, Yusri
    Attar, Ricardo M.
    BLOOD, 2016, 128 (22)
  • [7] Integrated Pharmacokinetic/Pharmacodynamic Model of a Bispecific CD3xCD123 DART Molecule in Nonhuman Primates: Evaluation of Activity and Impact of Immunogenicity
    Campagne, Olivia
    Delmas, Audrey
    Fouliard, Sylvain
    Chenel, Marylore
    Chichili, Gurunadh R.
    Li, Hua
    Alderson, Ralph
    Scherrmann, Jean-Michel
    Mager, Donald E.
    CLINICAL CANCER RESEARCH, 2018, 24 (11) : 2631 - 2641
  • [8] Phase 1 Cohort Expansion of Flotetuzumab, a CD123xCD3 Bispecific Dart® Protein in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Uy, Geoffrey L.
    Rettig, Michael P.
    Vey, Norbert
    Godwin, John
    Foster, Matthew C.
    Rizzieri, David A.
    Arellano, Martha L.
    Topp, Max S.
    Huls, Gerwin
    Jongen-Lavrencic, Mojca
    Martinelli, Giovanni
    Paolini, Stefania
    Ciceri, Fabio
    Carrabba, Matteo Giovanni
    Sweet, Kendra L.
    Ravandi, Farhad
    Church, Sarah E.
    Vadakekolathu, Jayakumar
    Rutella, Sergio
    Sun, Jichao
    Yang, Kang
    Baughman, Jan
    Curtis, Teia
    Timmeny, Erin
    Cali, Kerri
    Tran, Kathy
    Muth, John
    La Motte-Mohs, Ross
    Poirot, Camille
    Pallis, Athanasios
    Cesano, Alessandra
    Bonvini, Ezio
    Wigginton, Jon
    Lowenberg, Bob
    Davidson-Moncada, Jan K.
    DiPersio, John F.
    BLOOD, 2018, 132
  • [9] A phase I, first-in-human study of MGD006/S80880 (CD123 x CD3 DART) in AML/MDS.
    Vey, Norbert
    Davidson-Moncada, Jan Kenneth
    Uy, Geoffrey L.
    Rizzieri, David
    Khoury, Hanna Jean
    Foster, Matthew Charles
    Godwin, John E.
    Topp, Max S.
    Martinelli, Giovanni
    Ciceri, Fabio
    Carrabba, Matteo Giovanni
    Huls, Gerwin A.
    Wegener, Antje
    Tran, Kathy C.
    Shannon, Michele
    Sun, Jichao
    Wigginton, Jon M.
    DiPersio, John F.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Preclinical characterization of MGD013, a PD-1 x LAG-3 bispecific DART® molecule
    La Motte-Mohs, Ross
    Shah, Kalpana
    Brown, Jennifer G.
    Smith, Doug
    Gorlatov, Sergey
    Ciccarone, Valentina
    Tamura, James K.
    Li, Hua
    He, Leilei
    Vasanwala, Farha
    Shoemaker, Christine
    Li, Jonathan
    Saini, Shereen
    Rillema, Jill R.
    Licea, Monica
    Hill, Jessica
    Whiddon, Arin
    Pascuccio, Massimiliano
    Chen, Francine Z.
    De Costa, Anushka
    Easton, Ann
    Lung, Peter
    Stahl, Kurt
    Nordstrom, Jeffrey
    Koenig, Scott
    Bonvini, Ezio
    Johnson, Syd
    Moore, Paul A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345